Mometasone furoate instructions -
Looking for:
Mometasone furoate instructions.Mometasone Nasal Spray |
Mometasone furoate instructions
If you are a consumer or patient please visit this version. Nasal spray: 50 mcg of mometasone furoate, USP in each spray 3. Patients with known hypersensitivity to mometasone furoate or any of the ingredients of mometasone furoate nasal spray.
Mometasone furoate nasal spray 50 mcg is indicated for the prophylaxis of the nasal symptoms of seasonal allergic rhinitis in adult and pediatric patients 12 years and older. Mometasone furoate nasal spray 50 mcg is indicated for the treatment of chronic rhinosinusitis with nasal polyps in adult patients 18 years of age and older. Prior to initial use of mometasone furoate nasal spray, the pump must be primed by actuating ten times or until a fine spray appears. The pump may be stored unused for up to 1 week without repriming.
The recommended dosage for prophylaxis treatment of nasal symptoms of seasonal allergic rhinitis in adult and pediatric patients 12 years and older is mometasone furoate 2 sprays 2 sprays deliver a total of mcg of mometasone furoate in each nostril once daily total daily dose of mcg.
In patients with a known seasonal allergen that precipitates nasal symptoms of seasonal allergic rhinitis, prophylaxis with 2 sprays 2 sprays deliver a total of mcg of mometasone furoate in each nostril once daily total daily dose of mcg is recommended 2 to 4 weeks prior to the anticipated start of the pollen season.
The recommended dosage for the treatment of chronic rhinosinusitis with nasal polyps in adults 18 years and older is mometasone furoate 2 sprays 2 sprays deliver a total of mcg of mometasone furoate in each nostril twice daily total daily dose of mcg. A dose of 2 sprays 2 sprays deliver a total of mcg of mometasone furoate in each nostril once daily total daily dose of mcg is also effective in some patients.
Mometasone furoate nasal spray is contraindicated in patients with known hypersensitivity to mometasone furoate or any of its ingredients [see Warnings and Precautions 5. Epistaxis was observed more frequently in patients with allergic rhinitis and patients with chronic rhinosinusitis with nasal polyps who received mometasone furoate nasal spray than those who received placebo [see Adverse Reactions 6.
Localized infections of the nose and pharynx with Candida albicans has occurred from nasal administration of mometasone furoate. When such an infection develops, use of mometasone furoate nasal spray should be discontinued and appropriate local or systemic therapy instituted, if needed.
Instances of nasal septum perforation occurred in patients following the nasal application of corticosteroids, including mometasone furoate. As with any long-term topical treatment of the nasal cavity, patients using mometasone furoate nasal spray over several months or longer should be examined periodically for possible changes in the nasal mucosa.
Because of the inhibitory effect of corticosteroids on wound healing, patients who have experienced recent nasal septum ulcers, nasal surgery, or nasal trauma should not use a nasal corticosteroid until healing has occurred. Glaucoma and cataracts may be reported with systemic and topical including nasal, inhaled and ophthalmic corticosteroid use. Consider referral to an ophthalmologist in patients who develop ocular symptoms or use mometasone furoate long term [see Adverse Reactions 6 ].
Hypersensitivity reactions including instances of wheezing may occur after the nasal administration of mometasone furoate. Discontinue mometasone furoate nasal spray if such reactions occur [see Contraindications 4 ]. Persons who are on drugs which suppress the immune system are more susceptible to infections than healthy individuals. Chickenpox and measles, for example, can have a more serious or even fatal course in nonimmune children or adults on corticosteroids. In such children or adults who have not had these diseases, particular care should be taken to avoid exposure.
How the dose, route, and duration of corticosteroid administration affect the risk of developing a disseminated infection is not known.
If exposed to chickenpox, prophylaxis with varicella zoster immune globulin VZIG may be indicated. If exposed to measles, prophylaxis with pooled intramuscular immunoglobulin IG may be indicated.
If chickenpox develops, treatment with antiviral agents may be considered. Corticosteroids should be used with caution, if at all, in patients with active or quiescent tuberculous infection of the respiratory tract, or in untreated fungal, bacterial, systemic viral infections, or ocular herpes simplex because of the potential for worsening of these infections.
Hypercorticism and adrenal suppression may occur when nasal corticosteroids, including mometasone furoate, are used at higher-than-recommended dosages [see Dosage and Administration 2 ] or in patients at risk for such effects. If such changes occur, the dosage of mometasone furoate nasal spray should be discontinued slowly, consistent with accepted procedures for discontinuing oral corticosteroid therapy. Corticosteroids, including mometasone furoate, may cause a reduction in growth velocity when administered to pediatric patients.
Routinely, monitor the growth of pediatric patients receiving mometasone furoate nasal spray. The following clinically significant adverse reactions are described elsewhere in labeling:. Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
Adults and pediatric patients 12 years of age and older. In controlled U. A total of adult and pediatric patients 12 years and older have been treated for one year or longer. Adverse reactions did not differ significantly based on age, sex, or race. Four percent or less of patients in clinical trials discontinued treatment because of adverse events and the discontinuation rate was similar for the vehicle and active comparators.
In controlled clinical studies, the types of adverse reactions observed in patients with chronic rhinosinusitis with nasal polyps were similar to those observed in patients with allergic rhinitis. A total of adult patients ages 18 to 86 years received mometasone furoate nasal spray at doses of mcg once or twice daily for up to 4 months for treatment of chronic rhinosinusitis with nasal polyps.
Nasal ulcers and nasal and oral candidiasis were also reported in patients treated with mometasone furoate nasal spray primarily in patients treated for longer than 4 weeks.
The following adverse reactions have been identified during the post-marketing period for mometasone furoate nasal spray: nasal burning and irritation, anaphylaxis and angioedema, disturbances in taste and smell, nasal septal perforation, and vision blurred. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
No formal drug-drug interaction studies have been conducted with mometasone furoate nasal spray. Studies have shown that mometasone furoate is primarily and extensively metabolized in the liver of all species investigated and undergoes extensive metabolism to multiple metabolites. In vitro studies have confirmed the primary role of cytochrome CYP3A4 in the metabolism of this compound. Concomitant administration of CYP3A4 inhibitors may inhibit the metabolism of, and increase the systemic exposure to, mometasone furoate and potentially increase the risk for systemic corticosteroid side effects.
Caution should be exercised when considering the co-administration of mometasone furoate nasal spray with long-term ketoconazole and other known strong CYP3A4 inhibitors e. Consider the benefit of co-administration versus the potential risk of systemic corticosteroid effects, in which case patients should be monitored for systemic corticosteroid side effects. Mometasone is minimally absorbed systemically following nasal use, and maternal use is not expected to result in fetal exposure to the drug.
Available data from observational studies of mometasone use in pregnant women are insufficient to evaluate for a drug-associated risk of major birth defects, miscarriage or other adverse maternal or fetal outcomes. However, experience with oral corticosteroids suggests that rodents are more prone to teratogenic effects from corticosteroid exposure than humans.
The estimated background risk of major birth defects and miscarriage for the indicated population is unknown. All pregnancies have a background risk of birth defect, loss, or other adverse outcomes.
In the U. In another reproductive toxicity study, pregnant rats were dosed with mometasone furoate throughout pregnancy or late in gestation. Embryofetal development studies were conducted with pregnant rabbits dosed with mometasone furoate by either the topical dermal route or oral route throughout the period of organogenesis.
In the study using the topical dermal route, mometasone furoate caused multiple malformations in fetuses e. There are no available data on the presence of mometasone furoate nasal spray in human milk, the effects on the breastfed child, or the effects on milk production.
However, mometasone is minimally absorbed systemically by the mother following nasal use, and breastfeeding is not expected to result in exposure of the infant to mometasone. The safety and effectiveness of mometasone furoate nasal spray for prophylaxis of the nasal symptoms of seasonal allergic rhinitis in pediatric patients 12 years of age and older have been established [see Adverse Reactions 6.
Use of mometasone furoate nasal spray for this indication is supported by evidence from controlled trials in adult and pediatric patients 12 years of age and older [see Clinical Studies The safety and effectiveness of mometasone furoate nasal spray for the treatment of chronic rhinosinusitis with nasal polyps in pediatric patients less than 18 years of age have not been established. Effectiveness was not demonstrated in one 4-month trial conducted to evaluate the safety and efficacy of mometasone furoate in the treatment of chronic rhinosinusitis with nasal polyps in pediatric patients 6 to 17 years of age.
The primary objective of the study was to evaluate safety; efficacy parameters were collected as secondary endpoints. A total of patients with chronic rhinosinusitis with nasal polyps were randomized to placebo or mometasone furoate nasal spray mcg once or twice daily patients 6 to 11 years of age or mcg once or twice daily patients 12 to 17 years of age.
The results of this trial did not support the efficacy of mometasone furoate nasal spray in the treatment of chronic rhinosinusitis with nasal polyps in pediatric patients. The adverse reactions reported in this trial were similar to the adverse reactions reported in patients 18 years of age and older with chronic rhinosinusitis with nasal polyps. Controlled clinical studies have shown nasal corticosteroids may cause a reduction in growth velocity in pediatric patients.
This effect has been observed in the absence of laboratory evidence of hypothalamic-pituitary-adrenal HPA axis suppression, suggesting that growth velocity is a more sensitive indicator of systemic corticosteroid exposure in pediatric patients than some commonly used tests of HPA axis function.
The long-term effects of this reduction in growth velocity associated with nasal corticosteroids, including the impact on final adult height, are unknown. The growth of pediatric patients receiving nasal corticosteroids, including mometasone furoate nasal spray, should be monitored routinely e.
The potential growth effects of prolonged treatment should be weighed against clinical benefits obtained and the availability of safe and effective noncorticosteroid treatment alternatives. A clinical study to assess the effect of mometasone furoate nasal spray mcg total daily dose on growth velocity has been conducted in pediatric patients 3 to 9 years of age with allergic rhinitis.
No statistically significant effect on growth velocity was observed for mometasone furoate nasal spray compared to placebo following one year of treatment.
No evidence of clinically relevant HPA axis suppression was observed following a minute cosyntropin infusion. The potential of mometasone furoate nasal spray to cause growth suppression in susceptible patients or when given at higher doses cannot be ruled out. A total of patients above 64 years of age with allergic rhinitis or chronic rhinosinusitis with nasal polyps age range 64 to 86 years have been treated with mometasone furoate nasal spray for up to 3 or 4 months, respectively.
Concentrations of mometasone furoate appear to increase with severity of hepatic impairment [see Clinical Pharmacology There are no data available on the effects of acute or chronic overdosage with mometasone furoate nasal spray. Because of low systemic bioavailability, and an absence of acute drug-related systemic findings in clinical studies, overdose is unlikely to require any therapy other than observation.
Chronic overdosage with any corticosteroid may result in signs or symptoms of hypercorticism [see Warnings and Precautions 5. Mometasone furoate anhydrous, USP is a white to off-white powder, with an empirical formula of C 27 H 30 Cl 2 O 6and a molecular weight of It is practically insoluble in water; slightly soluble in methanol, ethanol, and isopropanol; soluble in acetone and chloroform; and freely soluble in tetrahydrofuran.
Its partition coefficient between octanol and water is greater than 5, Mometasone furoate nasal spray 50 mcg is a metered-dose, manual pump spray unit containing an aqueous suspension of mometasone furoate, USP in an aqueous medium containing benzalkonium chloride, citric acid, glycerin, microcrystalline cellulose and carboxymethylcellulose sodium, polysorbate 80 and sodium citrate.
The pH is between 4. Mometasone furoate nasal spray is a corticosteroid demonstrating potent anti-inflammatory properties. The precise mechanism of corticosteroid action on allergic rhinitis is not known. Corticosteroids have been shown to have a wide range of effects on multiple cell types e. In two clinical studies utilizing nasal antigen challenge, mometasone furoate nasal spray decreased some markers of the early- and late-phase allergic response.
These observations included decreases vs. The clinical significance of these findings is not known. The effect of mometasone furoate nasal spray on nasal mucosa following 12 months of treatment was examined in 46 patients with allergic rhinitis. There was no evidence of atrophy and there was a marked reduction in intraepithelial eosinophilia and inflammatory cell infiltration e. Adrenal Function in Adults: Four clinical pharmacology studies have been conducted in humans to assess the effect of mometasone furoate nasal spray at various doses on adrenal function.
❿Mometasone furoate instructions -
DailyMed - MOMETASONE FUROATE- mometasone spray, metered.
Advisory OTP, Please Verify Again. Do you have an Account. How To Use:Once daily or as fixed. Practo only provides reference source for common information on pimples and does not guarantee its accuracy or exhaustiveness.
Back to Medicines A to Z. Mometasone nasal nose spray is used to treat cold-like symptoms caused by allergic rhinitis. This is inflammation of the inside of the nose that can be brought on by hay fever.
Mometasone is also used to treat other conditions, such as nasal polyps in adults. Mometasone is a type of medicine known as a steroid or corticosteroid. Corticosteroids are a copy of a hormone that your body makes naturally. They are not the same as anabolic steroids. Mometasone nasal spray is available on prescription for adults and children. Adults can buy it from pharmacies for treating symptoms caused by allergic rhinitis, where it is often sold as Clarinaze. Most adults can use mometasone nasal spray for nasal polyps, allergic rhinitis and hay fever.
Children aged 3 years and over can use mometasone nasal spray for allergic rhinitis and hay fever. Mometasone is not suitable for some people.
To make sure this nasal spray is safe for you, tell your doctor if you:. For allergic rhinitis the usual dose is 1 or 2 sprays into each nostril once a day.
Do not use more than 2 sprays per nostril in 24 hours. For nasal polyps the usual dose is 1 or 2 sprays into each nostril once or twice a day. Do not use more than 4 sprays per nostril in 24 hours. If you're using a new bottle, it may not work first time. Pump the spray a few times until a fine mist comes out. You'll also need to do this if the bottle has not been used for a few days.
After using your spray, wipe the nozzle with a clean tissue and replace the cap. You'll be able to use your nasal spray less often once your symptoms are under control. For example, you might go from using 2 sprays in each nostril once a day, to 1 spray in each nostril once a day. You may need to increase your dose again if your symptoms get worse after reducing it. If you have mometasone nasal spray on prescription, your doctor will tell you how often to use the nasal spray and when to change your dose.
If you forget to take a dose, use it as soon as you remember. Unless it's almost time for your next dose, in which case skip the missed dose and take your next one as usual.
If you forget doses often, it may help to set an alarm to remind you. You could also ask your pharmacist for advice on other ways to help you remember to take your medicine.
Using too much mometasone nasal spray by accident is unlikely to harm you. Like all medicines, mometasone can cause side effects although not everyone gets them. With mometasone nasal spray, very little medicine is absorbed into the rest of your body, so it's not likely to give you serious side effects. Ask your doctor if you need to carry a steroid emergency card. Keep taking the medicine but talk to your doctor if these side effects bother you or do not go away:.
Very few people have serious side effects when using mometasone nasal spray. You are more likely to have a serious side effect if you use high doses of mometasone for more than a few months. It's possible to have a serious allergic reaction anaphylaxis to mometasone. These are not all the side effects of mometasone. See the leaflet inside your medicine's packet for a full list. You can report any suspected side effect to the UK safety scheme. There's no clear evidence that mometasone will harm your unborn baby.
For safety, your doctor will only prescribe mometasone in pregnancy if the benefits outweigh the risks. They will prescribe the lowest dose that works for you. If you're pregnant, speak to your doctor before buying mometasone nasal spray at a pharmacy or supermarket. However, always check with your doctor first. Your baby may need extra monitoring if you use mometasone nasal spray twice a day for more than a few months. For more information about how using a steroid nasal spray might affect you and your baby during pregnancy, read this leaflet on treating allergic rhinitis on the Best Use of Medicines in Pregnancy BUMPs website.
Some medicines and mometasone can affect each other. This can increase your chances of side effects, or it may mean changing your mometasone dose. There's very little information about taking herbal remedies and supplements while taking mometasone. Ask a pharmacist for advice. Tell your doctor or pharmacist if you're taking any other medicines, including herbal remedies, vitamins or supplements. Mometasone is a steroid corticosteroid medicine. Steroids closely copy the effects of natural hormones produced in your adrenal glands.
The adrenal glands are above your kidneys. Mometasone works on your immune system to reduce the symptoms of inflammatory conditions and allergic reactions, such as redness, swelling and itching.
The nasal spray reduces swelling and mucus in your nose. It can take a little longer to work than antihistamine sprays but the effects last for longer. If you're using it to treat nasal polyps, mometasone will reduce swelling and reduce the size of the polyps.
You will not notice any immediate improvement in your symptoms when you first start using mometasone nasal spray. It takes a few days for a steroid nasal spray to start working. It can take several weeks to reach its full effect. If you use the spray for hay fever it is best to start using it at least a couple of weeks before the hay fever season starts. If you buy mometasone nasal spray from a pharmacy or supermarket, check the leaflet that comes with the medicine.
This will tell you how long you can use it for. You can usually use it for up to 3 months, but tell your doctor if you feel no better after using it for 14 days. If you are prescribed mometasone, your doctor may advise you to use it for longer.
Mometasone is unlikely to have any lasting harmful effects if you follow the instructions that come with your medicine, or use it as recommended by your doctor. However, children and teenagers need to have their height and weight monitored carefully if they're using high doses of a steroid nasal spray like mometasone for a long time. Taking mometasone for a long time can slow down their normal growth. The nasal spray delivers a small amount of steroid medicine exactly where you need it.
This limits the amount of steroid reaching the rest of your body. It also keeps the risk of side effects as low as possible. If you're using steroid medicines such as mometasone, your adrenal glands may not make as much of some of the hormones your body needs such as cortisol known as the stress hormone. This is known as adrenal insufficiency. This card is the size of a credit card and fits in your wallet or purse. If you need any medical or dental treatment, or are having surgery or an invasive procedure, show your steroid emergency card to your doctor or dentist.
This is important so they know you're having steroid treatment and can give you extra steroids as needed. Mometasone does not affect any type of contraception, including the contraceptive pill and emergency contraception. There's no clear evidence to suggest that using mometasone will reduce fertility in either men or women. However, speak to a pharmacist or your doctor if you are trying to get pregnant.
For most people, taking mometasone nasal spray will not affect their ability to drive a car or cycle. Page last reviewed: 28 July Next review due: 28 July Mometasone nasal spray - Brand names: Clarinaze, Nasonex On this page About mometasone nasal spray Key facts Who can and cannot take mometasone nasal spray How and when to take mometasone nasal spray Side effects of mometasone nasal spray How to cope with side effects of mometasone nasal spray Pregnancy and breastfeeding Cautions with other medicines Common questions about mometasone nasal spray.
About mometasone nasal spray Mometasone nasal nose spray is used to treat cold-like symptoms caused by allergic rhinitis. It also comes as: a cream, ointment or scalp lotion for eczema and psoriasis an inhaler puffer for asthma skin treatments for eczema and psoriasis. You need to use mometasone nasal spray regularly for it to work. It works by reducing swelling and irritation in your nose. The most common side effects are an unpleasant smell and a dry or sore nose or throat.
Unders can only use mometasone nasal spray if their doctor prescribes it. If your doctor has prescribed high doses of mometasone to control your symptoms you may need to carry a steroid emergency card. Ask your pharmacist or doctor. To make sure this nasal spray is safe for you, tell your doctor if you: are allergic to mometasone or any other medicines are taking or have recently taken other steroid medicines have had nose surgery have an infection in your nose are pregnant or trying to get pregnant have ever had TB tuberculosis have ever had glaucoma or cataracts.
Mometasone nasal spray needs to be used regularly for it to work. How to use it Follow the instructions that come with your nasal spray. Gently shake the bottle and remove the cap.
Blow your nose gently, then close one nostril with your finger. Bend your head forward slightly and carefully put the nozzle into your other nostril. Slowly breathe in through your nose and press down on the widest part of the nozzle to squirt the spray once.
Adults and children 12 years of age and older—2 sprays in each nostril once a day. Each spray contains 50 micrograms (mcg) of mometasone. Shake the bottle. To use the spray, remove the protective cap. Close one nostril by pressing it with your finger. Tilt your head slightly forward and, keeping the bottle upright. Mometasone is in a class of medications called corticosteroids. It works by activating natural substances in the skin to reduce swelling. Mometasone Furoate 50 micrograms/dose Nasal Spray, suspension is indicated for use in adults and children 3 years of age and older to treat the symptoms of. Important: Important If you need any medical or dental treatment, or are having surgery or an invasive procedure, show your steroid emergency card to your doctor or dentist. Use mometasone exactly as directed. Do not spray it into your mouth or eyes. Information: You can report any suspected side effect to the UK safety scheme. Ask your doctor if you have any questions.Drug information provided by: IBM Micromedex. Mometasone nasal spray is used to treat and prevent the symptoms eg, stuffy or runny nose, itching, sneezing of seasonal short-term and perennial year-round allergic rhinitis hay fever. This medicine is also used to treat nasal polyps in adults. Mometasone belongs to the family of medicines known as corticosteroids cortisone-like medicines.
It works by preventing certain cells from releasing substances that cause an allergic reaction. In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:. Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines.
Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully. Appropriate studies have not been performed on the relationship of age to the effects of mometasone nasal spray to treat symptoms of allergic rhinitis in children younger than 2 years of age, to prevent seasonal allergic rhinitis in children younger then 12 years of age, and to treat nasal polyps in children younger than 18 years of age.
Safety and efficacy have not been established. Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of mometasone nasal spray in the elderly.
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below.
The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive. Using this medicine with any of the following medicines is not recommended.
Your doctor may decide not to treat you with this medication or change some of the other medicines you take. Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:. Use this medicine only as directed by your doctor. Do not use more of this medicine than your doctor ordered because it may increase the chance of absorption through the lining of the nose and result in unwanted effects.
This medicine usually comes with patient information leaflet and patient instructions. Read and follow the instructions carefully. Ask your doctor if you have any questions. This medicine is for use only in the nose. Do not get any of it into your eyes or on your skin. If it does get in these areas, rinse them with water right away and call your doctor. This medicine must be used regularly as ordered by your doctor.
It usually begins to work in about 2 days, but up to 2 weeks may pass before you feel its full effects. Check with your doctor before using this medicine for nasal problems other than the one for which it was prescribed, since it should not be used on many bacterial, viral, or fungal nasal infections. The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine.
If your dose is different, do not change it unless your doctor tells you to do so. The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine. If you miss a dose of this medicine, take it as soon as possible.
However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses. Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing. Throw away the bottle after you have used sprays, even if there is still some medicine left in it.
It is best to keep track of the number of sprays used so you will know when it is time to throw the bottle away. It is very important that your doctor check your or your child's progress at regular visits to make sure this medicine is working properly and to check for unwanted effects.
If your or your child's symptoms do not improve within a few days or if they become worse, check with your doctor. This medicine may cause fungus infection of the mouth or throat thrush. Tell your doctor right away if you have white patches in the mouth or throat, or pain when eating or swallowing. This medicine may increase your risk of having problems with your nose.
Check with your doctor right away if you or your child have bloody mucus, sores inside the nose, or unexplained nosebleeds while you are using this medicine. Check with your doctor immediately if blurred vision, difficulty in reading, or any other change in vision occurs during or after treatment. Your doctor may want your eyes be checked by an ophthalmologist eye doctor. If you or your child have difficulty with breathing, or any allergic reaction to this medicine, check with your doctor right away.
Avoid close contact with anyone who has chickenpox or measles if you have never had these conditions before. This is especially important for children. Tell your doctor right away if you think you have been exposed to chickenpox or measles. Using too much of this medicine or using it for a long time may increase your risk of having adrenal gland problems.
Talk to your doctor if you or your child have more than one of these symptoms while using this medicine: darkening of the skin, diarrhea, dizziness, fainting, loss of appetite, mental depression, nausea, skin rash, unusual tiredness or weakness, or weight loss.
This medicine may cause children to grow more slowly than usual. Talk to your child's doctor if you have any concerns. Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription over-the-counter [OTC] medicines and herbal or vitamin supplements.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention. Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:.
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional. Call your doctor for medical advice about side effects. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.
Any use of this site constitutes your agreement to the Terms and Conditions and Privacy Policy linked below. Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission.
Mayo Clinic does not endorse any of the third party products and services advertised. A single copy of these materials may be reprinted for noncommercial personal use only.
Drugs and Supplements Mometasone Nasal Route. Description and Brand Names Drug information provided by: IBM Micromedex US Brand Name Nasonex Descriptions Mometasone nasal spray is used to treat and prevent the symptoms eg, stuffy or runny nose, itching, sneezing of seasonal short-term and perennial year-round allergic rhinitis hay fever.
Legal Conditions and Terms Any use of this site constitutes your agreement to the Terms and Conditions and Privacy Policy linked below. Advertising Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission.
Advertising and sponsorship policy Advertising and sponsorship opportunities. Reprint Permissions A single copy of these materials may be reprinted for noncommercial personal use only.
Comments
Post a Comment